DCF — MERCYONE SIOUXLAND MEDICAL CENTER
Enterprise Value: $-131.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-131.1M
Enterprise Value
$-43.8M
PV of Cash Flows
$-87.2M
PV of Terminal Value
$-140.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $152.6M | $-6.9M | -5.0% | $-13.3M | $-12.1M |
| Year 2 | $157.2M | $-5.5M | -4.0% | $-12.2M | $-10.0M |
| Year 3 | $161.9M | $-4.0M | -3.0% | $-10.9M | $-8.2M |
| Year 4 | $166.8M | $-3.3M | -2.0% | $-10.4M | $-7.1M |
| Year 5 | $171.8M | $-3.0M | -2.0% | $-10.3M | $-6.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-131.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$148.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000002699364395
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5